Bovilis® Vista® 5 VL5 SQ, 50 Dose

This product has been shown effective for the vaccination of healthy cattle 6 months of age or older against respiratory disease and abortion due to infectious bovine rhinotracheitis (IBR), respiratory disease and fetal infection, including persistently infected calves due to bovine virus diarrhea virus (BVD) Types 1 & 2, bovine respiratory syncytial virus (BRSV) and parainfluenza₃ virus (PI₃), reproductive disease caused by Campylobacter fetus and leptospirosis (caused by Leptospira canicola, L. grippotyphosa, L. hardjo - including the L. borgpetersenii serovar hardjo bovis, L. icterohaemorrhagiae, and L. pomona). Reproductive Duration of immunity has been shown to be at least 217 days for IBR and at least 206 days for BVD (Types 1 & 2). Respiratory Duration of immunity has been demonstrated to be at least 182 days for IBR, and at least 206 days for BVD Type 1 and at least 200 days for BVD Type 2. Duration of immunity for BRSV, PI₃, C. fetus and Leptospira spp. has not been established. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

Respiratory and reproductive efficacy and duration of immunity has been demonstrated against disease caused by the BVD Type 1b strain.

This product has been shown to be effective against urinary shedding of L.hardjo organisms.

SAFETY: Safe for use in pregnant heifers and cows or calves nursing pregnant cows provided the cows and heifers in the herd are vaccinated prior to breeding, within the previous 12 months, with any of the modified live IBR and BVD containing vaccine(s) in this product line.